A new study published in the Journal of Investigative Medicine has found that the SMHS Clinical and Translational Research Scholarly Concentration is effective in training physician-researchers.
Hoth Therapeutics, Inc. has entered into a sponsored research agreement with GW to explore the potential use of Aprepitant for topical and/or systemic therapy to counter the dermatological related side-effects of Erlotinib therapy in cancer patients.
Congratulations to Dara Baker, third-year MD student at the George Washington University School of Medicine and Health Sciences (SMHS), who was named as a fellow in the National Institutes of Health’s (NIH) 2019–20 Medical Research Scholars Program (MRSP).
A recent survey found patients with psoriasis frequently use complementary or alternative therapies to treat their symptoms
Cherinne Arundel, MD; Gurusher Panjrath, MD; Charles Faselis, MD; Richard M. Allman, MD; and Ali Ahmed, MD, MPH, all of SMHS, authored a study finding that patients with heart failure who have a systolic blood pressure less than 130 mmHg are at a higher risk of worse outcomes.
“Incorporating the Arts to Improve the Health and Wellbeing of Washington, D.C.” brought out community leaders and clinicians to the 6th Annual Rodham Institute Summit.